SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bharat Parenterals inches up on receiving order worth $27 million

29 Jan 2025 Evaluate

Bharat Parenterals is currently trading at Rs. 1275.00, up by 1.00 points or 0.08% from its previous closing of Rs. 1274.00 on the BSE.

The scrip opened at Rs. 1275.00 and has touched a high and low of Rs. 1275.00 and Rs. 1275.00 respectively. So far 5 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 1870.00 on 02-Dec-2024 and a 52 week low of Rs. 774.25 on 01-Feb-2024.

Last one week high and low of the scrip stood at Rs. 1445.00 and Rs. 1216.00 respectively. The current market cap of the company is Rs. 878.04 crore.

The promoters holding in the company stood at 67.20%, while Institutions and Non-Institutions held 0.65% and 32.15% respectively.

Bharat Parenterals has received a $27 million (around Rs 232 crore) order for the supply of high-demand pharmaceutical products over the next 18-24 months. This is largest order that the company has ever won and this milestone reflects the company’s commitment to delivering quality healthcare solutions and reinforces its leadership in the global pharmaceutical market.

Bharat Parenterals is engaged in to the business of the Pharmaceuticals & Drugs.


Bharat Parenterals Share Price

1213.10 32.30 (2.74%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×